TCL Archive FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA October 19, 1979
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training November 27, 1998
TCL Archive NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening September 17, 1993
